This hottest twist while in the Lykos Therapeutics saga threatens A serious overhaul of the company’s technique and route, with Musk ally and billionaire investor Antonio Gracias appearing to want to consider the organization again towards its nonprofit drug advancement roots and a more Doblinite philosophy.By far the most hotly argued Tale, obvi